Table 3.

Survival and recurrence rates among patients with MCC by primary anatomic site

	All Patients (n=80)	HN (n=42)	NHN (n=38)	P
Median follow up (IQR), Months	34.5 (22–57)	30.1 (21–49)	37.0 (27–59)	0.15
3-year event rate (%)
Local recurrence-free survival	94	94	94	0.97
Nodal recurrence-free survival	87	89	85	0.71
Regional recurrence-free survival	88	82	94	0.14
Distant metastasis-free survival	90	92	89	0.69
Recurrence-free survival	76	73	80	0.44
MCC-specific survival	90	88	91	0.69
Overall survival	81	75	86	0.06